Insel, R.A.* ; Dunne, J.L.* ; Atkinson, M.A.* ; Chiang, J.L.* ; Dabelea, D.* ; Gottlieb, P.A.* ; Greenbaum, C.J.* ; Herold, K.C.* ; Krischer, J.P.* ; Lernmark, A.* ; Ratner, R.E.* ; Rewers, M.J.* ; Schatz, D.A.* ; Skyler, J.S.* ; Sosenko, J.M.* ; Ziegler, A.-G.
Staging presymptomatic type 1 diabetes: A scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
Diabetes Care 38, 1964-1974 (2015)
Insights from prospective, longitudinal studies of individuals at risk for developing type 1 diabetes have demonstrated that the disease is a continuum that progresses sequentially at variable but predictable rates through distinct identifiable stages prior to the onset of symptoms. Stage 1 is defined as the presence of β-cell autoimmunity as evidenced by the presence of two or more islet autoantibodies with normoglycemia and is presymptomatic, stage 2 as the presence of β-cell autoimmunity with dysglycemia and is presymptomatic, and stage 3 as onset of symptomatic disease. Adoption of this staging classification provides a standardized taxonomy for type 1 diabetes and will aid the development of therapies and the design of clinical trials to prevent symptomatic disease, promote precision medicine, and provide a framework for an optimized benefit/risk ratio that will impact regulatory approval, reimbursement, and adoption of interventions in the early stages of type 1 diabetes to prevent symptomatic disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2015
Prepublished in Year
HGF-reported in Year
2015
ISSN (print) / ISBN
0149-5992
e-ISSN
1935-5548
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 38,
Issue: 10,
Pages: 1964-1974
Article Number: ,
Supplement: ,
Series
Publisher
American Diabetes Association
Publishing Place
Alexandria, Va.
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502100-001
Grants
Copyright
Erfassungsdatum
2015-10-12